CryoLife reported Q4 2020 financial results with total revenues of $67.9 million, a net loss of $(3.5) million, or $(0.09) per share, and a non-GAAP net income of $7.9 million, or $0.20 per share.
Total revenues reached $67.9 million, a 3% decrease compared to Q4 2019.
Net loss amounted to $(3.5) million, or $(0.09) per share.
Non-GAAP net income was $7.9 million, or $0.20 per share.
The company completed the integration of Ascyrus and launched new JOTEC products.
Due to continued uncertainties resulting from the COVID-19 global pandemic, the Company is not issuing 2021 financial guidance at this time.
Analyze how earnings announcements historically affect stock price performance